David R. Holmes, Jr., MD, MACC, and Thomas Munger, MD, FACC, implant a Watchman left atrial appendage closure device with structural heart disease fellows Mohamad Alkhouli, MD, and Mohammad Sarraf, MD. Ijioma assists with the procedure. The Mayo Clinic and Holmes were actively involved with the Watchman device feasibility study, and have been involved in all five clinical trials of the Watchman left atrial appendage closure device, which was approved by the U.S. Food and Drug Administration for atrial fibrillation in March 2015.

Click here to see more >>>